Decibel Cannabis Company has expanded its global footprint by entering into a supply agreement to provide dried medical cannabis flower to 4C LABS, a healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution, and clinical development in cannabis-based medicinal products for human health in the United Kingdom and Channel Islands (the "UK").
- Decibel to supply 4C LABS with Qwest branded, craft-quality Medical Cannabis for distribution to UK medical cannabis patients
- Decibel to grant strain exclusivity of rare and unique cultivars to be distributed by 4C LABS
- 3-year supply agreement
- Initial shipment expected before year-end
- Minimum purchase commitments achieve exclusivity over certain genetics and QWEST brands in the UK
"We are excited to partner with 4C LABS, a leading organization in the growing medical cannabis industry in the UK that echoes Decibel's commitment to quality and patient care. Not only will this unlock a strong partnership and a new market for Decibel's craft cannabis products, but it also sets the stage for further growth into other European markets," said Adam Coates, Chief Revenue Officer. "Decibel's success with Qwest flower products in Canada and in Israel's medical market reinforces the demand for premium cannabis products and the reputation we have built to service that demand."
"4C LABS is building a patient-focused best-in-class product line for the UK & Channel Islands, the Qwest craft flower line strengthens the top end of the 4C LABS product offerings. Decibel's innovative craft quality Qwest flower products will fill an empty segment in the UK market and bring a world-class BC Cannabis product to UK patients," said Greg Dobbin, CEO of 4C LABS. "Decibel's success in Canada, the most competitive cannabis market in the world, is a product of hard work, innovation, and attention to detail, qualities that will resonate with UK patients."